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Purpose. To use the meta-analytic approach to examine the eﬀects of diet (D), aerobic exercise (E), or both (DE) on non-high-
density lipoprotein cholesterol (non-HDL-C) in adults. Methods. Randomized controlled trials in adults ≥18 years of age were
included. A mixed-eﬀect model was used to combine eﬀect size (ES) results within each subgroup and to compare subgroups
(Qb). Heterogeneity was examined using the Q and I2 statistics, and 95% conﬁdence intervals (CI) were also calculated. Statistical
signiﬁcance was set at P ≤ 0.05, while a trend for statistical signiﬁcance was set between P>0.05, and ≤0.10. Results. A statistically
signiﬁcant exercise minus control group decrease in non-HDL-C was found for DE (7 ESs, 389 participants, x =− 11.1mg/dL,
95% CI =− 21.7t o−0.6,P = 0.04,Q = 2.4,P = 0.88,I2 = 0%),atrendfortheDgroup(7ESs,402participants,x =− 8.5mg/dL,
95% CI =− 18.6t o1 . 6 ,P = 0.10, Q = 0.76, P = 0.99, I2 = 0%), and no change for the E group (7 ESs, 387 participants,
x = 3.0mg/dL, 95% CI =− 7.1 to 13.1, P = 0.56, Q = 0.78, P = 0.99, I2 = 0%). Overall, no statistically signiﬁcant between-group
diﬀerences were found (Qb = 4.1, P = 0.12). Conclusions. Diet combined with aerobic exercise may reduce non-HDL-C among
adults in some settings.
1.Introduction
Cardiovascular disease is a major public health problem
aﬀectinganestimated82.6millionadultsintheUnitedStates
(USA) [1]. In terms of mortality, heart disease is the leading
cause of death in the USA, aﬀecting 616,628 people (25% of
all deaths) in 2008 [2]. Not surprisingly, the economic costs
associated with cardiovascular disease are also high. In 2008,
the annual direct and indirect costs of cardiovascular disease
in the USA were estimated to be $297.7 billion [1].
Less than optimal levels of lipids and lipoproteins are a
major risk factor for cardiovascular morbidity and mortality
in adults [1]. According to recent estimates, 33.6 million
USA adults have total cholesterol (TC) levels ≥240mg/dL,
71.3 million have low-density-lipoprotein cholesterol (LDL-
C) levels ≥130mg/dL and 41.8 million have high-density
lipoprotein cholesterol (HDL-C) levels ≤40mg/dL [1].
Currently, the primary target of lipid-lowering therapy
in adults is low-density lipoprotein cholesterol (LDL-C)
withnon-high-densitylipoproteincholesterol(non-HDL-C)
recommended as a secondary target of therapy in adults
with triglyceride levels ≥200mg/dL [3]. However, it has been
suggested that non-HDL-C may be a more relevant target
for lipid-lowering therapy because it contains all the lipids
and lipoproteins considered to be atherogenic (low-density
lipoprotein cholesterol, lipoprotein (a), intermediate-density
lipoprotein, very-low-density lipoprotein) [4, 5]. Indeed,
previous meta-analytic research has shown that non-HDL-
C is a better predictor than LDL-C for future cardiovascular
risk. For example, Boekholdt et al. found that non-HDL-
C was a better predictor than LDL-C for future risk
of cardiovascular events in statin-treated patients [6]. In
addition, another meta-analysis found that over a 10-year
period, a focus on lowering non-HDL-C versus LDL-C
would prevent 300,000 more fatal or nonfatal ischemic
cardiovascular events [7]. From a practical perspective, the
assessment of non-HDL-C versus LDL-C may be preferred
because (1) it can be assessed in the nonfasting state,2 Cholesterol
(2) incurs no additional costs because it is calculated as
the diﬀerence between TC and HDL-C, and (3) has well-
documented beneﬁts [5].
Aerobic exercise and diet are ﬁrst-line lifestyle inter-
ventions recommended for improving lipids and lipopro-
teins, including LDL-C, in adults [3]. Recently, aggregate
data meta-analytic research of randomized controlled trials
addressing the eﬀects of diet (D), aerobic exercise (E), or
both (DE) on lipids and lipoproteins in adults were reported
by the authors [8]. Interventions had to last at least 4
weeks with diet including any type previously considered
to improve lipids and lipoproteins in adults (low saturated
fat, caloric restriction, etc.) [3]. For both the D and DE
groups, statistically signiﬁcant intervention minus control
(C) group improvements were observed for TC, LDL-C,
and triglycerides (TG), but not HDL-C. For the E groups,
improvements were limited to TG. When between-group
comparisons were conducted, reductions in TC and LDL-
C were greater in both the D and DE groups versus E
group (P<0.05). No other between-group diﬀerences were
observed. Unfortunately, none of the studies reported data
for non-HDL-C, including dispersion data. In this brief
paper, we use an existing method for estimating measures
of dispersion for non-HDL-C based on data reported for
TC and HDL-C [9] in order to conduct a meta-analysis
on the eﬀects of D, E, or both on non-HDL-C in adult
humans.
2. Methods
2.1. Study Eligibility, Data Sources, Data Extraction, and
Risk of Bias Assessment. Study eligibility, data sources, data
extraction, and risk of bias assessment have been previously
described in detail elsewhere [8]. Brieﬂy, studies in any
language were included if they were randomized controlled
trials ≥4 weeks that included D, E, DE, and C groups in
adults ≥18 years of age and in which mean and dispersion
data for TC and HDL-C were available for calculating non-
HDL-C. Data sources included searching nine electronic
databases, cross-referencing, and expert review. Dual data
extraction occurred using predeveloped codebooks. Risk of
biaswasassessedbybothauthors,independentofeachother,
using the Cochrane Risk of Bias Assessment instrument [10].
2.2. Statistical Analysis
2.2.1. Calculation of Treatment Eﬀects from Each Study. The
primary outcome for this meta-analysis was treatment eﬀect
changes in non-HDL-C. First, each intervention (D, E,
DE) and Control (C) group result was calculated as the
change outcome diﬀerence in TC minus the change outcome
diﬀerence in HDL-C. Second, the variance for non-HDL-C
f o re a c hr e s u l tf r o me a c hg r o u p( D ,E ,D E ,C )w a sc a l c u l a t e d
by pooling the variances of the change outcome diﬀerences
for TC and HDL-C. Third, treatment eﬀect changes in non-
HDL-C were calculated as the intervention (D, E, DE) minus
the C result. Variances for these changes were calculated by
pooling intervention (D, E, DE) and C results [9].
2.2.2. Pooling of Treatment of Eﬀects. Am i x e de ﬀects model
wasusedtopoolnon-HDL-Ctreatmenteﬀects(intervention
minus control) for each group (D, E, DE) from each
study and to compare results across the three groups. This
consisted of a random-eﬀects model to combine studies
within each group (D, E, DE) and a ﬁxed-eﬀect model
to compare results between groups (Qb). Study-to-study
variance (tau-squared) was not assumed to be equal for all
subgroups. A z-score alpha value of ≤0.05 (two-tailed) was
considered statistically signiﬁcant while alpha values >0.05
but ≤0.10 were considered as a trend. Precision of treatment
eﬀects estimates for non-HDL-C was determined using two-
tailed 95% conﬁdence intervals (CIs) based on z. Estimation
of treatment eﬀects for non-HDL-C in a new trial was
calculated using 95% prediction intervals (PI) [11–13]. Any
statistically signiﬁcant outliers (P ≤ 0.05) were deleted from
the model.
Heterogeneity of results for each group was examined
using the Q and I2 statistics [14, 15]. The alpha value for
statistical signiﬁcance for Q was set at P ≤ 0.10. For I2,
values of 25% to <50% were considered small, 50% to <75%
medium, and ≥75% large [15]. Potential bias due to small-
study eﬀects was examined using a funnel plot along with
the data imputation approach of Duval and Tweedie [16,
17]. Simple, mixed-eﬀects meta-regression was conducted
to examine the eﬀects of age, baseline non-HDL-C, and
intervention minus control group changes in body weight on
changes in non-HDL-C in each group (D, E, DE). A two-
tailed alpha value of ≤0.05 was considered as a statistically
signiﬁcant association while alpha values >0.05 and ≤0.10
were considered as a trend.
All data were analyzed using Comprehensive Meta-
Analysis (version 2.2) [18], Microsoft Excel 2007 [19], and
SSC-Stat (version 2.18) [20].
3. Results
Six studies representing 788 men and women (D = 207, E =
192, DE = 194, C = 195) from 28 groups (7 groups each for
D, E, DE, and C) met all eligibility criteria [21–26]a n dh a v e
beendescribed in detailelsewhere[8].Thebaselinebetween-
study range for all groups combined was 34 to 57 years for
age (x ± SD = 46.5 ± 6.5 years), 63 to 100kg for bodyweight
(x±SD = 80.8 ± 13.4kg), 180 to 254mg/dL for TC (x±SD =
213.6 ± 22.0mg/dL), and 36 to 63mg/dL for HDL-C (x±SD
= 48.3 ± 7.7mg/dL).
Baseline values for non-HDL-C are shown in Table 1,
group changes in Table 2, and study-level changes in
(Figure 1). As can be seen, there was a statistically signiﬁcant
intervention minus control group decrease for non-HDL-
C in the DE group, a trend for a statistically signiﬁcant
decrease in the D group, and no statistically signiﬁcant
change in the E group. Nonoverlapping 95% conﬁdence
intervals were also observed for the DE group. However, for
all groups, the 95% PI for changes in non-HDL-C included
zero (0). Changes in non-HDL-C were equivalent to −6.5%,
−5.6% and 0.8%, respectively, for DE, D, and E groups.
No outliers or heterogeneity were observed. In addition,Cholesterol 3
Study name Group by intervention Statistics for each study
Point estimate and 95% CI
Point estimate Lower limit Upper limit
Hellenius et al. [21] G1-Diet −3.5 −47.4 40.4
Favors intervention Favors control
60 30 0 −30 −60
Hopewell [22] G1-Diet −9.4 −28.1 9.3
Nieman et al. [23] G1-Diet −16.2 −41.9 9.5
Stefanick et al. [24] Men G1-Diet −8.7 −37.7 20.3
Stefanick et al. [24] Women G1-Diet −6.2 −35.2 22.8
Vetro [25] G1-Diet −1.4 −26.3 23.5
Wing et al. [26] G1-Diet −10.8 −43.7 22.1
G1-Diet −8.5 −18.6 1.6
Hellenius et al. [21] G2-Exercise −0.8 −37.8 36.2
Hopewell [22] G2-Exercise 6.8 −15.1 28.7
Nieman et al. [23] G2-Exercise 2.3 −25.1 29.7
Stefanick et al. [24] Men G2-Exercise −2.7 −32.5 27.1
Stefanick et al. [24] Women G2-Exercise −6.0 −36.7 24.7
Vetro [25] G2-Exercise 6.7 −13.1 26.5
Wing et al. [26] G2-Exercise 5.4 −28.0 38.8
G2-Exercise 3.0 −7.1 13.1
Hellenius et al. [21] G3-Diet and Exercise −12.0 −57.4 33.4
Hopewell [22] G3-Diet and Exercise −9.2 −28.5 10.1
Nieman et al. [23] G3-Diet and Exercise −21.7 −45.6 2.2
Stefanick et al. [24] Men G3-Diet and Exercise −17.3 −46.9 12.3
Stefanick et al. [24] Women G3-Diet and Exercise −14.4 −44.0 15.2
Vetro, [25] G3-Diet and Exercise 6.7 −25.3 38.7
Wing et al. [26] G3-Diet and Exercise −2.7 −37.3 31.9
G3-Diet and Exercise −11.1 −21.7 −0.6
Figure 1: Forest plot for intervention minus control group changes in non-HDL-C according to Diet, Exercise and Diet and Exercise
interventions. The black squares for each result represent the diﬀerence in non-HDL-C in mg/dL while the left and right extremes of
the squares represent the corresponding 95% conﬁdence intervals. The middle of the black diamond for the three groups represent the
overall mean diﬀerence while the left and right extremes of the diamonds represent the corresponding 95% conﬁdence intervals based on a
random-eﬀects model. To convert mg/dL to mmol, divide by 38.67.
Table 1: Baseline values for non-HDL-C (mg/dL).
Group Studies# Groups# Participants# x ± SD Range Median
Diet 6 7 207 169.0 ± 20.3 136–192 167
Exercise 6 7 192 160.9 ± 29.3 121–192 167
Diet and exercise 6 7 194 168.9 ± 26.4 130–201 162
Control 6 7 195 162.7 ± 24.3 135–192 159
#Number; x ±SD, mean ± standard deviation; to convert from mg/dL to mmol, divide by 38.67.
Table 2: Changes in non-HDL-C (mg/dL).
Variable Studies# Participants#
(I + C)
ES# x (95% CI)
(mg/dL)
P Q(P) I2 (%) 95% PI
Diet 6 402 7 −8.5 (−18.6, 1.6) 0.10∗∗ 0.8 (0.99) 0 −21.7, 4.8
Exercise 6 389 7 3.0 (−7.1, 13.1) 0.60 0.8 (0.99) 0 −10.3, 16.3
Diet + Exercise 6 387 7 −11.1 (−21.7, −0.6) 0.04∗ 2.4 (0.88) 0 −24.4, 2.1
#Number; ES: eﬀect sizes; x (95% CI), mean ± 95% conﬁdence intervals; P:a l p h av a l u ef o rc h a n g e si nn o n - H D L - C ;Q(P): Cochran’s Q statistic and associated
alpha value; I2 (%): percentage of inconsistency; 95% PI: 95% prediction intervals; I + C: intervention + control; ∗statistically signiﬁcant at P ≤ 0.05; ∗∗trend
(>0.05 to ≤0.10) for statistical signiﬁcance; To convert changes in mg/dL to mmol, divide by 38.67.4 Cholesterol
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Figure2:Funnelplotforinterventionminuscontrolgroupchanges
in non-HDL-C across all results. The x-axis represents changes in
non-HDL-C in mg/dL, while the y-axis represents the standard
error of the changes in non-HDL-C in mg/dL. The middle of the
hollow diamond represents the original overall mean diﬀerence,
while the left and right extremes of the diamond represent the
corresponding 95% conﬁdence intervals based on a random-eﬀects
model. The middle of the black solid diamond represents the mean
diﬀerenceinnon-HDL-C,adjustedforsmall-studyeﬀects,whilethe
left and right extremes of the diamond represent the corresponding
95% conﬁdence intervals based on a random-eﬀects model. As can
be seen by the matching diamonds, no adjustment (imputation)
was necessary. To convert mg/dL to mmol, divide by 38.67.
no small-study eﬀects were found as the funnel plot was
generally symmetrical and no data points had to be imputed
(Figure 2). When between-group changes in non-HDL-C
were calculated, no statistically signiﬁcant diﬀerence was
observed (Qb = 4.2, P = 0.13). No statistically signiﬁcant or
trend for a statistical association was found between changes
in non-HDL-C and age, initial non-HDL-C, and changes in
bod y weight (P>0.10 for all).
4. Discussion
To the best of the authors’ knowledge, this is the ﬁrst
meta-analytic study to examine the eﬀects of D, E, and DE
on changes in non-HDL-C in adult humans. The overall
ﬁndingssuggestthatDEreducesnon-HDL-Cinadults,while
there was a trend for statistically reductions in the D group.
No statistically signiﬁcant reductions were found for the E
group. The observed changes in non-HDL-C for the DE
and D groups were almost entirely the result of statistically
signiﬁcant decreases in TC and little or no change in HDL-C
[8].
The approximate 7% decrease observed in the DE group
may be clinically important. A recent meta-analysis by
Robinson et al. found that most lipid-modifying drugs used
asmonotherapyhaveanapproximateonetoonerelationship
between percent non-HDL-C lowering and reduction in
coronary heart disease [27]. Assuming that the same beneﬁts
could be achieved as a result of the current interventions,
this would result in an approximate 7% reduction in
coronary heart disease in the DE groups and an approximate
6% reduction in the D group. The National Cholesterol
Education Program currently recommends a target for non-
HDL-C, that is, 30mg/dL higher than the target for LDL-
C[ 3]. Given the current ﬁndings, it appears that DE, and
possibly D, may contribute to achieving that goal.
No statistically signiﬁcant associations were found
between changes in non-HDL-C and age, initial non-HDL-
C and changes in body weight. While these results are
interesting, they should be interpreted with caution since
studies in a meta-analysis are not randomly assigned to
predictors [28]. Therefore, these potential predictors should
be tested in large, randomized controlled trials.
While the results of this study suggest that DE, and
possibly D, reduce non-HDL-C in adults, they should be
interpreted with respect to the following. First, the 95% PI
includedzero(0)forallgroups.Thissuggeststhatreductions
in non-HDL-C may not occur in every setting. Second, given
the small number of studies included as well as missing data,
a determination of the optimal diet and dose of aerobic
exercise needed to reduce non-HDL-C in adults could not be
elucidated. Given the need to determine such, it is suggested
that future randomized controlled trials address this issue.
Third, because none of the studies reported non-HDL-C,
variances were estimated based on the data reported for TC
and HDL-C. This could have possibly led to results that
are diﬀerent than if the original variance statistics had been
available. Given the former, it is strongly suggested that
future studies report non-HDL-C, including the variance
statistics for such. Fourth, the results of this study, like most
studies, should not be generalized beyond the characteristics
of the participants included.
5. Conclusions
Combined diet and aerobic exercise may reduce non-
HDL-C among adults in some settings. However, future
randomized controlled trials are needed before any ﬁnal
recommendations can be made.
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